SQ-2201

N/A

Report date: 2024/04/18 16:21:48

Base Information

Drug NameSQ-2201

Drug Alias NameSQ-2201SQP22+SQT01SQ2201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionApoptosis stimulantsMitosis inhibitorsTubulin inhibitors +[5]

TargetsTubulinReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsSolid tumoursNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesShasqi Inc

China Registration ClassN/A

Develop Information

Active CompaniesShasqi Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A